STAGE III FALLOPIAN TUBE CANCER AJCC V8
Clinical trials for STAGE III FALLOPIAN TUBE CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III FALLOPIAN TUBE CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III FALLOPIAN TUBE CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise in shrinking ovarian tumors before surgery
Disease control OngoingThis early-phase trial is testing the drug olaparib in 15 people with newly diagnosed BRCA-mutant ovarian, fallopian tube, or peritoneal cancer before they have surgery. The goal is to see if taking olaparib for two cycles can safely shrink tumors and stop them from growing. Olap…
Matched conditions: STAGE III FALLOPIAN TUBE CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New drug combo shows promise for Hard-to-Treat BRCA cancers
Disease control OngoingThis early-phase study tests a combination of two drugs (niraparib and dostarlimab) in 18 people with advanced breast, pancreas, or ovary cancers that have a BRCA gene mutation and have stopped responding to standard treatments. The goal is to see if the combo can shrink tumors b…
Matched conditions: STAGE III FALLOPIAN TUBE CANCER AJCC V8
Phase: PHASE1 • Sponsor: University of Washington • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New drug combo shows promise in ovarian cancer safety trial
Disease control OngoingThis early-phase study tested adding the experimental drug ipatasertib to standard chemotherapy (paclitaxel and carboplatin) for people with stage III or IV ovarian, fallopian tube, or primary peritoneal cancer. The main goals were to find the safest dose and check for side effec…
Matched conditions: STAGE III FALLOPIAN TUBE CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
Massive biobank aims to unlock Cancer's secrets
Knowledge-focused OngoingThis study collects tissue and blood samples, along with medical information, from 1,600 people with various advanced cancers. Researchers will store and study these samples over time to learn how cancer changes and why some treatments stop working. The goal is to improve future …
Matched conditions: STAGE III FALLOPIAN TUBE CANCER AJCC V8
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 07, 2026 18:40 UTC